Effects of Replacing High Protein Foods in People With Chronic Kidney Disease
Part of paid clinical trials in West Lafayette, Indiana.
- Sponsor
- Indiana University
- Study ID
- NCT07105670
- Status
- Recruiting
Conditions
- Chronic Kidney Disease Stage 3
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Controlled dietary intervention — OTHERParticipants will complete a 2-week baseline period consuming their standard diet without any food or beverages provided followed by a randomized, crossover-controlled feeding study of a lacto-ovo vegetarian diet versus the same diet with 20% of the protein replaced by red meat. In between the two diets, there will be a five-week washout where participants will consume their standard diet without any food or beverages provided.
Study Details
The goal of this crossover clinical trial is to explore the effects of red meat intake on serum and fractional urinary excretion of uremic toxins including trimethylamine N-oxide in people with chronic kidney disease.
Key Dates
- Start date
- Jul 1, 2026
- Status verified
- May 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 15 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: Lacto-ovo vegetarian diet alone; then lacto-ovo vegetarian with red meat dietParticipants will be assigned to a lacto-ovo vegetarian diet providing 0.8 g/kg/day of protein for the first treatment period; they will then be assigned to continue this diet with 20% of the protein replaced by red meet for the second treatment period.
- Experimental: Lacto-ovo vegetarian with red meat diet; then lacto-ovo vegetarian diet aloneParticipants will be assigned to a lacto-ovo vegetarian diet with 20% of the protein replaced by red meat for the first treatment period; they will then be assigned to a lacto-ovo vegetarian diet alone for the second treatment period.
Primary Outcome Measure
Serum trimethylamine N-oxide [ Time Frame: 13 Weeks (collections in week 1, 2, 4, 5, 9, 10, 12, 13 which corresponds to before and during the last two weeks of each of the three-week controlled diet periods). ]
Central Contacts
- Brandon Kistler765-494-5406
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Purdue University | West Lafayette | Indiana | 47906 |
Find similar trials in West Lafayette, IN
By research site
Related Studies
- A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)PHASE1/PHASE2 · Recruiting · AION Healthspan, Inc. · Miami, Florida